Sleeve Gastrectomy Device Market

ID: MRFR/HC/37475-HCR 100 Pages Rahul Gotadki Last Updated: September 17, 2026
Sleeve Gastrectomy Device Market Research Report: Size, Share, Trend Analysis By Device Type (Disposable Devices, Reusable Devices, Energy-based Devices), By End Users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Procedure Type (Open Surgery, Laparoscopic Surgery), By Patient Demographics (Adult Patients, Adolescent Patients, Geriatric Patients) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
Sleeve Gastrectomy Device Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.97%
2024 Market Size$ 7.49 Billion
2025 Market Size$ 8.01 Billion
2035 Market Size$ 15.72 Billion
Key Players
Medtronic
Johnson & Johnson
Boston Scientific
Stryker
B. Braun Melsungen AG
Conmed Corporation
Opportunities
  • Rising Obesity Rates
  • Supportive Reimbursement Policies
  • Growing Focus on Preventive Healthcare
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Device Type (USD Billion)
      1. 4.1.1 Disposable Devices
      2. 4.1.2 Reusable Devices
      3. 4.1.3 Energy-based Devices
    2. 4.2 Healthcare, BY End User (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Ambulatory Surgical Centers
      3. 4.2.3 Specialty Clinics
    3. 4.3 Healthcare, BY Procedure Type (USD Billion)
      1. 4.3.1 Open Surgery
      2. 4.3.2 Laparoscopic Surgery
    4. 4.4 Healthcare, BY Patient Demographics (USD Billion)
      1. 4.4.1 Adult Patients
      2. 4.4.2 Adolescent Patients
      3. 4.4.3 Geriatric Patients
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boston Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Stryker (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 B. Braun Melsungen AG (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Conmed Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Intuitive Surgical (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Ethicon (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY DEVICE TYPE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY PROCEDURE TYPE
    6. 6.6 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    7. 6.7 CANADA MARKET ANALYSIS BY DEVICE TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY END USER
    9. 6.9 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
    10. 6.10 CANADA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY DEVICE TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY END USER
    14. 6.14 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
    15. 6.15 GERMANY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    16. 6.16 UK MARKET ANALYSIS BY DEVICE TYPE
    17. 6.17 UK MARKET ANALYSIS BY END USER
    18. 6.18 UK MARKET ANALYSIS BY PROCEDURE TYPE
    19. 6.19 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    20. 6.20 FRANCE MARKET ANALYSIS BY DEVICE TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY END USER
    22. 6.22 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
    23. 6.23 FRANCE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    24. 6.24 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY END USER
    26. 6.26 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
    27. 6.27 RUSSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    28. 6.28 ITALY MARKET ANALYSIS BY DEVICE TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY END USER
    30. 6.30 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
    31. 6.31 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    32. 6.32 SPAIN MARKET ANALYSIS BY DEVICE TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY END USER
    34. 6.34 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
    35. 6.35 SPAIN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY DEVICE TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY END USER
    43. 6.43 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
    44. 6.44 CHINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    45. 6.45 INDIA MARKET ANALYSIS BY DEVICE TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY END USER
    47. 6.47 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
    48. 6.48 INDIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    49. 6.49 JAPAN MARKET ANALYSIS BY DEVICE TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY END USER
    51. 6.51 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
    52. 6.52 JAPAN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    57. 6.57 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY END USER
    59. 6.59 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
    60. 6.60 MALAYSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    61. 6.61 THAILAND MARKET ANALYSIS BY DEVICE TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY END USER
    63. 6.63 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
    64. 6.64 THAILAND MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    65. 6.65 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY END USER
    67. 6.67 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
    68. 6.68 INDONESIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    69. 6.69 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY END USER
    71. 6.71 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
    72. 6.72 REST OF APAC MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY END USER
    76. 6.76 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
    77. 6.77 BRAZIL MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    78. 6.78 MEXICO MARKET ANALYSIS BY DEVICE TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY END USER
    80. 6.80 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
    81. 6.81 MEXICO MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    82. 6.82 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY END USER
    84. 6.84 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
    85. 6.85 ARGENTINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    99. 6.99 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY END USER
    101. 6.101 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
    102. 6.102 REST OF MEA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.2.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.3.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.3.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.4.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.4.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.5.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.5.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.6.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.6.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.7.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.7.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.8.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.8.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.9.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.9.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.10.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.10.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.11.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.11.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.12.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.12.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.13.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.13.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.14.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.14.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.15.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.15.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.16.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.16.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.17.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.17.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.18.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.18.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.19.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.19.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.20.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.20.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.21.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.21.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.22.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.22.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.23.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.23.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.24.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.24.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.25.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.25.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.26.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.26.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.27.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.27.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.28.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.28.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.29.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.29.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.30.3 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      4. 7.30.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Sleeve Gastrectomy Device Market Segmentation

Sleeve Gastrectomy Device Market By Device Type (USD Billion, 2025-2035)

  • Disposable Devices
  • Reusable Devices
  • Energy-based Devices

Sleeve Gastrectomy Device Market By End User (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Sleeve Gastrectomy Device Market By Procedure Type (USD Billion, 2025-2035)

  • Open Surgery
  • Laparoscopic Surgery

Sleeve Gastrectomy Device Market By Patient Demographics (USD Billion, 2025-2035)

  • Adult Patients
  • Adolescent Patients
  • Geriatric Patients
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.